Crispr Therapeutics shares owned by Opus Point Partners Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Opus Point Partners Management
from 13F filings
Historical chart of Opus Point Partners Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Opus Point Partners Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Opus Point Partners Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2019-09-30 | $542k | 13k | 41.02 |
| 2019-06-30 | $622k | 13k | 47.07 |
| 2019-03-31 | $472k | 13k | 35.72 |
More positions owned by Opus Point Partners Management
View all positions for Opus Point Partners Management